AIRLINK 197.50 Decreased By ▼ -0.47 (-0.24%)
BOP 10.01 Decreased By ▼ -0.03 (-0.3%)
CNERGY 7.16 Decreased By ▼ -0.13 (-1.78%)
FCCL 36.50 Increased By ▲ 0.50 (1.39%)
FFL 16.67 Decreased By ▼ -0.24 (-1.42%)
FLYNG 25.60 Increased By ▲ 0.56 (2.24%)
HUBC 135.63 Increased By ▲ 1.60 (1.19%)
HUMNL 14.00 Decreased By ▼ -0.14 (-0.99%)
KEL 4.81 Increased By ▲ 0.03 (0.63%)
KOSM 6.95 Increased By ▲ 0.01 (0.14%)
MLCF 45.25 Increased By ▲ 0.27 (0.6%)
OGDC 218.00 Decreased By ▼ -0.23 (-0.11%)
PACE 6.95 Increased By ▲ 0.01 (0.14%)
PAEL 41.25 Decreased By ▼ -0.17 (-0.41%)
PIAHCLA 16.95 Increased By ▲ 0.09 (0.53%)
PIBTL 8.50 Increased By ▲ 0.04 (0.47%)
POWER 9.43 Increased By ▲ 0.04 (0.43%)
PPL 183.99 Decreased By ▼ -1.94 (-1.04%)
PRL 41.56 Increased By ▲ 0.29 (0.7%)
PTC 24.94 Increased By ▲ 0.17 (0.69%)
SEARL 103.70 Decreased By ▼ -0.95 (-0.91%)
SILK 1.03 Increased By ▲ 0.02 (1.98%)
SSGC 40.71 Decreased By ▼ -0.20 (-0.49%)
SYM 17.96 Decreased By ▼ -0.09 (-0.5%)
TELE 8.96 Increased By ▲ 0.05 (0.56%)
TPLP 12.80 Decreased By ▼ -0.04 (-0.31%)
TRG 66.90 Increased By ▲ 0.30 (0.45%)
WAVESAPP 11.36 Increased By ▲ 0.06 (0.53%)
WTL 1.79 Increased By ▲ 0.01 (0.56%)
YOUW 4.01 Increased By ▲ 0.01 (0.25%)
BR100 12,118 Increased By 9.1 (0.08%)
BR30 36,634 Increased By 36.5 (0.1%)
KSE100 115,077 Increased By 35 (0.03%)
KSE30 36,155 Decreased By -44.3 (-0.12%)

KARACHI: Federal Minister for Planning, Development and Special Initiatives Asad Umar said on Tuesday that the first locally-processed coronavirus vaccine in Pakistan was nothing short of a revolution, adding that while vaccines were in high demand all over the world, the Chinese-produced ones were "the most preferred" in Pakistan.

He made these remarks while addressing the launch ceremony of the locally processed 'PakVac' vaccine in Islamabad. The PakVac vaccine has been developed by China's state-run pharmaceutical company Cansino and is being brought to Pakistan in a concentrated form, where it is packaged at the National Institute of Health (NIH) in Islamabad. Cansino was the first Chinese vaccine to have undergone clinical trials in Pakistan and was administered to around 18,000 people.

Copyright Business Recorder, 2021

Comments

Comments are closed.